chrisvoncsefalvay/vaers-outcomes huggingface dataset:
LOSS OF TASTE; CHILLS; FEVER; This spontaneous report received from a patient concerned a 34 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced loss of taste. On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced fever. Treatment medications (dates unspecified) included: paracetamol, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, loss of taste and chills was not reported. This report was non-serious.
Dizzy; Weak; Tired; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): LRN4509846.  A 68 year-old male patient received bnt162b2 (BNT162B2), administration date 17Dec2021 (Batch/Lot number: unknown) at the age of 68 years as dose number unknown (booster), single for covid-19 immunisation. Relevant medical history included: "Primary-Progressive Multiple Sclerosis" (unspecified if ongoing); "Penicillin allergy" (unspecified if ongoing). Concomitant medication(s) included: OCREVUS; BACLOFEN; CYMBALTA. Vaccination history included: Covid-19 vaccine (Unknown manufacturer.), for Covid-19 Immunization. The following information was reported: DIZZINESS (non-serious) with onset 18Dec2021, outcome "not recovered", described as "Dizzy"; ASTHENIA (non-serious) with onset 18Dec2021, outcome "not recovered", described as "Weak"; FATIGUE (non-serious) with onset 18Dec2021, outcome "not recovered", described as "Tired". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a consumer refers to her 6 month old daughter. On 05-MAY-2014 the patient was vaccinated with first dose of GARDASIL, injection (dose and lot# not reported. The patient was supposed to receive an unspecified dose of an unspecified hepatitis b vaccine (recombinant) (manufacturer unknown). The patient was not feeling any adverse reactions. Additional information has been requested.
I started getting achy; Headache; Joint pain; I started developing congestion; Cough; Sore throat; Fatigue; This is a spontaneous report from a contactable consumer (patient). A 23-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EH9899) via an unspecified route of administration in right arm on 17Dec2020 at single dose for COVID-19 immunization. There was no medical history. There were no concomitant medications. The patient got the vaccine (Covid vaccine) on this past Thursday the 17 and he first didn't show any symptom or anything like that and then later at night and then in the beginning of morning of 18Dec2020, he started showing some symptoms. He started getting achy, he guessed little bit joint pain and started to get headache and didn't take too much of it neither of those side effects and as he found out last night apparently he had a positive exposure on the 18th the following day and didn't find out until last night but after the 18th he started showing different symptoms, he can't find better with the vaccine so he started developing congestion, cough, sore throat and a little bit of fatigue (all on Dec2020). He is going to get tested now and they have told him that the test, the vaccine should not affect the test itself. He received a medication for his headache. Treatment reported as the only thing he took was Tylenol. His height was about 5"8 or 5"9. Events outcome was unknown.
The following morning approximately 24 hours after injection I woke up with some throat tightness and angio edema. Eyes and lips swollen. I also experienced mild swelling throughout body.  My husband and I both work in healthcare since I did not have any difficulty breathing I was able to take my normal daily dose of Zyrtec plus Prilosec, Benadryl and some prednisone I have on hand for reactions. I did not seek medical attention as I have known allergy to shellfish and have the medications on hand at home. If the reaction did not subside after a medications I would have used an epipen and gone to the ED.
Booster given prior to 5 months post 2nd vaccine in primary series. 2nd vaccine Sept 4th 2021.
Strong pulse; Tinnitus; Elevated blood pressure; This is a spontaneous report from a contactable consumer (Patient). A 63-year-old female patient received BNT162B2 (COMIRANTY; Formulation: Solution for injection; Lot number: Unknown, Expiration date: was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. Medical history included high blood pressure, anxiety and overweight. Concomitant medications were not reported. On an unspecified date, patient experienced strong pulse, tinnitus and elevated blood pressure. The patient underwent lab tests and procedures which included Blood pressure: High on an unspecified date. Patient also reported she didn't know if the symptoms could be because she was nervous. Before getting the vaccine, she asked her doctor if it was okay for her to get it, since she has high blood pressure (caller stated she takes medication for this and it is under control), anxiety and overweight, and doctor said it was okay. If the second dose is stronger than the first one, should she still get the second dose?. The outcome of events were unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Rec'd Prevnar (pneumococcal 7-valent conjugate vaccine) on 11/13/01, presented to medical room on 11/15/01 with redness (3.25-3.75") and slight swelling and itching. Child denies pain at site. Rash allergic reaction to ?.
Large red painful rash. Appeared night after injection and was large for 24 hours then began to subside. Patient took antihistamines and ibuprofen and used a cold compress.
fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue). At the time of the report, FATIGUE (fatigue) outcome was unknown.
Bruise on the arm at the injection site after second dose; Itching at the injection site after the second dose; Pain at the injection site after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE BRUISING (Bruise on the arm at the injection site after second dose), INJECTION SITE PRURITUS (Itching at the injection site after the second dose) and INJECTION SITE PAIN (Pain at the injection site after the second dose) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021, the patient experienced INJECTION SITE BRUISING (Bruise on the arm at the injection site after second dose), INJECTION SITE PRURITUS (Itching at the injection site after the second dose) and INJECTION SITE PAIN (Pain at the injection site after the second dose). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency and VALACYCLOVIR [VALACICLOVIR] for Itching and Pain, at a dose of 1 g. At the time of the report, INJECTION SITE BRUISING (Bruise on the arm at the injection site after second dose), INJECTION SITE PRURITUS (Itching at the injection site after the second dose) and INJECTION SITE PAIN (Pain at the injection site after the second dose) outcome was unknown.            No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to MOD-2021-029506 (Patient Link).
After both doses of Moderna COVID-19 vaccine I developed a rash covering my torso within 36 hours. The rash was mildly itchy. After the second dose the rash also spread to my face and neck.
Bruise; Rash at the injection site; Injection site quite red; Injection site sore; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruise), VACCINATION SITE PRURITUS (Rash at the injection site), VACCINATION SITE ERYTHEMA (Injection site quite red) and VACCINATION SITE PAIN (Injection site sore) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no adverse event). Concomitant products included CHLORPHENIRAMINE MALEATE for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Rash at the injection site), VACCINATION SITE ERYTHEMA (Injection site quite red) and VACCINATION SITE PAIN (Injection site sore). On 31-Jan-2021, the patient experienced CONTUSION (Bruise). On 31-Jan-2021, VACCINATION SITE PRURITUS (Rash at the injection site), VACCINATION SITE ERYTHEMA (Injection site quite red) and VACCINATION SITE PAIN (Injection site sore) had resolved. At the time of the report, CONTUSION (Bruise) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient who had a Shingles case had recently completed Shingrix 2.; This case was reported by a other health professional via sales rep and described the occurrence of shingles in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age group was not reported, however it was captured as an adult as per vaccine indication. The age at vaccination was not reported. The reporter stated that patient had a shingles case and the patient had recently completed Shingrix 2. The reporter did not agree to follow up from GSK.
per the EUA, cases of COVID 19 that result in hospitalization or death are to be reported: This patient received Moderna 1/7 and on 1/16 they were COVID positive. Patient was admitted for pneumonia Length of stay 15 days
mom returned 445PM w/pt;area on lt thigh reddened w/knot;pt content @ present in fathers arm;mom contacted MD office regarding above;instructed to put warm wet compresses on thigh;notify MD if problem does not resolve;
First, my sincere apologies for the delay in reporting as I have only just learned of the VAERS program.  This is to report a series of two ANTHRAX innoculations received in 1999 (reported on separate forms), that may be a factor in prolonged and chronic health changes I have experienced since approx May 2001.  Of note, I was also exposed to Tuberculosis in that time frame and exhibited a positive PPD (20mm induration), and subsequently underwent TB preventative treatment with Isoniazid (INH). I have a detailed medical history of monthly visits and lab tests following the INH program and can provide copies.     An immediate and pronounced effect was noticed in May 2001 after the INH program began, most notably exhibited as extreme fatigue, joint pain, arthralgia, loss of range-of-motion, lower back pain, lack of stamina, and loss of strength.  The addition of B-6 to the INH regimen was began in July 2001 and some relief was noted.  Continued problem with joint pain caused me to be seen by the Rheumatology Clinic in Aug 01...no previous history of arthralgia.  After transfer in 2002, began experiencing increased kidney pain (LRQ), fatigue, short-term memory loss, and irregular heartbeat/palpitations.  Echocardiogram performed (negative), thyroid levels checked.  During entire period, Physical Fitness Test (PFT) performance continued to decline and failures were noted.  Generalized chest pain continued into 2004, self-admitted to ER on 17SEP04.  Stress test negative.  Began Prevacid treatment.  Honorably discharged in May 2005 before retirement.     Although the significant decline in health seemed to begin in May 2001 following INH treatment, I have found no linkages between INH side-effects and my experiences.  My concern is that this long-term effect, which persists to this day, is potentially connected with the Anthrax vaccinations received in 1999, and/or interactions between INH and the Anthrax vaccine.
Pt developed fever of 103F (ear) at 03:00 on 3/7/01 and a large area of erythema on left deltoid. 3/7/01 at 14:00, entire outer deltoid affected. Rx'd Motrin for fever and soreness.
Pt had tingly feeling after the vaccine, got itchy. patient developed red bump on arm 2 days later. Pt did not seek treatment.
Got both vaccines but still get a mild case/suspected vaccination failure; started on my back an came all around my torso under my breasts.; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had a terrible case of shingles started on  back an came all around torso under  breasts that was so painful an can not remember ever being so sick an in pain).   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date :24-Sep-2022 Reporters comment: This case was reported by a consumer via interactive digital media  The patient had shingles started on his/her back an came all around his/her torso under his/her breasts. that was so painful an he/she not remember ever being so sick an in pain after received the two shots of shingle vaccine Additional Supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.  .
Left hand numb, upper lip, left cheek, left foot/toes numb. Left hand cold compared to right. Told to report to local ER. Went to clinic this hospital. Admitted for CVA. Discharged 10/18/03 as reported by patient. 60-day follow up on 02/02/04: "No new information received."
6.5 hours after receiving vaccine began to feel muscle soreness throughout body especially in legs. 7 hours after receiving vaccine had 104 degree fever and chills which was reduced with acetaminophen. Throughout the following day, had a low grade fever of ~101 when not using acetaminophen and tiredness. Two days after receiving the vaccine, all side effect besides tiredness have subsided.
I'm feeling itchy on my left arm since day three of the shot....I feel like a mosquito bit me and I just want to continue scrating. This has be going on and still haven't stop. I'm trying not to scratch hard.....Please what can I do?
passed out after 1 day of having the vaccine; A spontaneous report was received from a consumer concerning a 66-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and passed out.  The patient's medical history as provided by the reporter included dementia. No concomitant medications were reported.  On an unknown date, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   On an unknown date, the patient passed out after one day of having vaccine. No treatment information was provided.   Action taken with mRNA-1273 in response to the event was not reported.  The outcome for the event, passed out was unknown.; Reporter's Comments: This case concerns a 66-year-old female patient, who experienced a serious unexpected event of Loss of consciousness. The event occurred approximately one day after first dose of mRNA-1273, lot # unknown. Treatment details were not provided. Based on the current available information and temporal association between the use of the product and onset of the event a causal relationship cannot be excluded.
Maculoapapular dermatitis 24 hrs p/inject w/screaming for almost 24 hrs;
pt recv vax & devel small blisters in clusters on stomach & one on face w/light red patchy places on rt legs;resembled contact dermatitis;
slightly sore arm for a week, then temporary relapse through this complaint time, especially sensitive after napping rest, weight lifting weakness with exercise. Patient  had adverse reaction to right arm after Pfizer #2, RE2613, GPWIMF,  Mar 17, 2021. Prior history 15 years of window washing with tense right arm. My employer, had major  injection to left head by dope addiction group, claiming percussion tap sensitivity to tooth #12. Skipped fake urgent root canal to #12, to do left poison injection that made left foot, ear, and left elbow sensitive Associates July 10, 2003, for quite some time. Patient is still getting weak sensitive right arm after Mar 17, 2021,  thru my complaint Oct 13. 2021, including right shoulder bursitis. Note the has a history of crashing into major electric transmission lines, like modern winds, and was moved. Patient suspects a type of current. Labor strike going on. Patient had right arm and foot stroke symptoms May 2011.
pt recvd vax & p/vax pt exp hair loss inc; pt exp hair loss w/1st dose of vax;
Headache,fever,chills,fatigue,sore arm,red itchy rash on arm
On the day of the shot at about 08:00pm I became dizzy and started to come down with a fever. I went home from work and stayed in bed for two days. The next day around 02:00 in the morning I had a massive migraine which lasted for 24 hours. Two days after receiving the shot I started to feel better.
My mental cycle has changed. (Before vacation) Day:1-spotting, Day:2- semi heavy, slightly uncomfortable cramping with no painkillers needed, one super tampon and will switch to regular tampons. Change tampons  after 2-3 hours of wearing them. Rest of cycle is light.  (After Vacation) Day:1-spotting , light cramping. Day:2- very heavy flow, needing multiple super tampons. Cramps are painful-needed a painkiller.   I had to leave work because of the bleeding and pain. Uncharacteristic of me. I haven?t had to ask to leave my job because of something like this before.  Last month was a little heavier than usual but I didn?t think much of it. This month is just really bad.
This spontaneous report as received from a registered nurse refers to a 6-month-old patient of unknown gender. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions, or allergies was provided. On 05-JAN-2017, the 6-month-old patient was vaccinated with the first dose of ROTATEQ oral liquid (orally; lot # M007311, expiration date 30-JAN-2017; dose was not provided). No adverse effect was reported. Additional information has been requested.
History of mast cell activation, had swelling of hands and itchiness after vaccine. Got Benadryl and famotidine at clinic. Arrived in ED 1047 discharged 1140. Narrative: 32M w/ MAST cell activation syndrome, p/w swelling of hands and itchiness after receiving covid vaccine. Denies SOB/CP/facial swelling/n/v/syncope. Was given benadryl and famotidine at the clinic and symptoms have significantly improved. 32M w/ pmhx as noted p/w possible allergic reaction. Vitals as above. Non-focal exam. Overall this appears consistent with allergy; pt has no signs/symptoms of anaphylaxis. I think it is reasonable to start him on a steroid burst. As his sx had significantly improved, I did not feel that an extended period of monitoring was necessary in the ED. He does have EpiPens that he carries on his person in the event of any severe reaction.
Slight fever; Felt weak, tired, lethargic; Felt weak, tired, lethargic; he administered the Pfizer-BioNTech COVID-19 Vaccine second dose to 3 Patients but he has drawn more than the required volume (0.5mL instead of 0.3mL).; Felt weak, tired, lethargic; typical soreness; flu like symptoms; This is a spontaneous report from contactable pharmacists. This Pharmacist reported similar events for 3 patients. This report is for 3rd of 3 patients. A 26-year-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection), dose 2 via an unspecified route of administration on 26Feb2021 (Batch/Lot Number: EL3302; Expiration Date: 28May2021) as DOSE 2, 0.5 ML SINGLE (at the age of 26-year-old) for covid-19 immunisation. The patient medical history was unknown. Historical vaccine included BNT162B2 dose 1 on 05Feb2021 Batch/Lot number: EL3302 exp 28Mar2021 for COVID-19 immunisation. The patient's concomitant medications were none. The patient did not take other vaccinations within four weeks prior to the first administration date of the suspect vaccine. The patient received the 2nd dose of the vaccine with overdose (administered .5 mg instead of .3mg to patient) on 26Feb2021 and felt weak and tired the next day. Slight fever next day after vaccination which did subside after using Tylenol. Felt weak, tired, lethargic. Has since resolved. Properly diluted vial so only slight overdose, not full vial overdose. Pharmacist monitored patient for a week and she has been fine after her symptoms resolved. She had the expected typical soreness and flu like symptoms for 24-48 hours. Therapeutic measures were taken as a result of slight fever. The outcome of the events Slight fever, Felt weak, tired, lethargic, typical soreness, flu like symptoms was recovered in 2021.  No follow-up attempts are possible. No further information is expected. Sender's Comments: Linked Report(s) :PFIZER INC-2021223835 Same reporter/drug/event, different patient. PFIZER INC-2021216069 Same reporter/drug/event, different patient.
about 1 hr p/vax began running fever, mom gave 1 dose APAP temp about 102 all noc 13JUL95 about 730PM called ER t105;parent put pt in water & gave 2nd dose of APAP;temp about 100 when emergency unit arrived t103.5;@ hosp t103.7